NEVVI Medicare utilization intelligence

← back

FRISBY, JAREDDO NPI 1649706243 Clinician

Infectious Disease · OVERLAND PARK, KS

Specialty Infectious Disease — from billed Medicare claims
Trained AT STILL UNIVERSITY OF HEALTH SCIENCES, COLLEGE OF OSTEO MED, KIRKSVILLE — medical school, self-reported to CMS
In practice about 9 years since medical school (class of 2017, self-reported to CMS)
Location OVERLAND PARK, KS · NPPES registered location
Active in data Billed Medicare 2022–2024 (3 consecutive years)
Scale 15 codes billed · 97,835 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20232026
METRO INFECTIOUS DISEASE CONSULTANTS LLC
2023–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2022-07

Year: 2024 · 2023 · 2022 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J0878 Injection, daptomycin, 1 mg
J0875 Injection, dalbavancin, 5 mg
J0897 Injection, denosumab, 1 mg
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
J0696 Injection, ceftriaxone sodium, per 250 mg
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
J1335 Injection, ertapenem sodium, 500 mg
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
36415 Insertion of needle into vein for collection of blood sample
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.